Both in Pharmaceuticals
Summit Therapeutics vs Protagonist Therapeutics
Over the past year SMMT returned −13.3% and PTGX returned +84.6%; their daily moves had a correlation of 0.35.
SMMT −13.3% PTGX +84.6%Growth of $1, one year, split-adjusted
| Metric | SMMT | PTGX |
|---|---|---|
| Price | $15.80 | $140.24 |
| Market cap | $12.60B | $9.07B |
| Today | +6.76% | +0.62% |
| 1 month | −8.5% | −0.3% |
| 6 months | −9.9% | +41.4% |
| Year to date | −9.7% | +60.6% |
| 1 year | −16.4% | +78.4% |
| Revenue growth (YoY) | — | +3749.2% |
| Gross margin | — | 100.0% |
| Net margin | — | 76.3% |
| P/E (TTM) | — | 109.5× |
| Price / sales | — | 32.2× |
| Net cash | $690.7M | $782.6M |
| Dividend yield | — | — |
| Volatility (60d) | 70.7% | 31.7% |
| Short % of float | 29.5% | 16.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).